View Featured Industry Events

  • This event has passed.

IS02: Breakthrough Innovation: The First and Only Bispecific T-cell Engager (BiTE®) Therapy for 2L+ Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

September 7 @ 12:00 – 13:00 PDT

Details

Date:
September 7
Time:
12:00 – 13:00 PDT
Event Category: